Findings

What do systematic reviews say?

10 questions · 10 findings · 5 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 5 · 50%GRADE not reported 0 · 0%Very low 3 · 30%Low 1 · 10%Moderate 1 · 10%High 0 · 0%

Early taxane‐based chemotherapy and androgen deprivation therapy (ADT) vs ADT only

Quality of life at 12 months (

1 finding from 1 review

Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 790 participants
Low

Cephalomedullary nails vs extramedullary implants

Health‐related quality of life, early (≤ 4 months) · older adults (> 60 years of age) with extracapsular hip fractures

The review found no eligible studies for this question.

1 finding from 1 review

Cephalomedullary nails versus extramedullary implants for extracapsular hip fractures in older adults 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Bipolar hemiarthroplasty vs unipolar hemiarthroplasty

HRQoL: using EQ‐5D (range from 0 to 1; higher values indicate better quality of life · adults with displaced and undisplaced hip fractures

1 finding from 1 review

Arthroplasties for hip fracture in adults 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 115 participants
Very low

Total hip arthroplasty vs hemiarthroplasty

HRQoL: using EQ‐5D (range from 0 to 1; higher values indicate better quality of life · adults with displaced and undisplaced hip fractures

1 finding from 1 review

Arthroplasties for hip fracture in adults 2022 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 279 participants
Very low

Cemented vs uncemented hemiarthroplasty

HRQoL: using EQ‐5D (range from 0 to 1; higher values indicate better quality of life · adults with displaced and undisplaced hip fractures

1 finding from 1 review

Arthroplasties for hip fracture in adults 2022 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 1122 participants
Moderate

Hydrocortisone vs placebo

Quality of life at 3 months · adults experiencing acute traumatic stress symptoms

1 finding from 1 review

Early pharmacological interventions for prevention of post‐traumatic stress disorder (PTSD) in individuals… 2024 · Cochrane Headline outcomes only
no estimate extracted
1 study · 43 participants
Very low

Escitalopram vs placebo

Quality of life at 3 months ‐ not measured · adults experiencing acute traumatic stress symptoms

The review found no eligible studies for this question.

1 finding from 1 review

Early pharmacological interventions for prevention of post‐traumatic stress disorder (PTSD) in individuals… 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Propranolol vs placebo

Quality of life at 3 months ‐ not measured · adults (aged 18 and older) exposed to a traumatic event

The review found no eligible studies for this question.

1 finding from 1 review

Early pharmacological interventions for universal prevention of post‐traumatic stress disorder (PTSD) 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Gabapentin vs placebo

Quality of life at 3 months ‐ not measured · adults (aged 18 and older) exposed to a traumatic event

The review found no eligible studies for this question.

1 finding from 1 review

Early pharmacological interventions for universal prevention of post‐traumatic stress disorder (PTSD) 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Hydrocortisone vs placebo

Quality of life at 3 months ‐ not measured · adults (aged 18 and older) exposed to a traumatic event

The review found no eligible studies for this question.

1 finding from 1 review

Early pharmacological interventions for universal prevention of post‐traumatic stress disorder (PTSD) 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found